Tisagenlecleucel Archives - Medical Conferences

Second-line tisa-cel similar to standard-of-care for R/R aggressive non-Hodgkin lymphoma

Presented By

Dr Michael Bishop, University of Chicago, IL, USA

Trial

Phase 3, BELINDA

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:11

Presented By

Dr Emmanuel Bachy, Hospices Civils de Lyon, France

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:01

Expert

Dr Emmanuel Bachy, Hospices Civils de Lyon, France

Trial

JULIET, ZUMA-1

Conference

ASH 2021

Type

News article

4 February 2022 10:15

Expert

Dr Michael R. Bishop, David and Etta Jonas Center for Cellular Therapy, University of Chicago, USA

Trial

Phase 3, BELINDA

Conference

ASH 2021

Type

News article

4 February 2022 10:03

Presented By

Dr Karl Kilgore, Avalere, USA

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 21:07